Schwan says India’s healthcare spend relative to GDP is very low, compared to economies such as China which spends about 5% to 6% of its GD...

A life sciences or medical product company is yet to make it big anywhere in India, despite a startup culture that is 15 years old.

India is not known for developing drugs, let along cancer drugs, but a few small and niche firms are trying exactly that, reports ET.

New and considerable optimism over cancer drugs will drive deal-making in pharma over the decade, with companies weak in this segment tryin...